Disseminated phaeohyphomycosis: review of an emerging mycosis
- PMID: 11797173
- DOI: 10.1086/338636
Disseminated phaeohyphomycosis: review of an emerging mycosis
Abstract
Disseminated phaeohyphomycosis is an uncommon infection caused by dematiaceous fungi, although the number of case reports about this infection has been increasing in recent years. A total of 72 cases are reviewed. Scedosporium prolificans is by far the most common cause. The presence of melanin in their cell walls may be a virulence factor for these fungi. The primary risk factor is decreased host immunity, although cases in apparently immunocompetent patients have been reported. Eosinophilia was seen in 11% of cases. Endocarditis is mostly reported on bioprosthetic valves, particularly those of porcine origin. The outcome of antifungal therapy remains poor, with an overall mortality rate of 79%. Special precautions taken for immunocompromised patients may help prevent exposure to fungi during the patients' period of greatest risk. The development of newer antifungal agents and combination therapy may hold promise in improving the management of these devastating infections in the future.
Comment in
-
Central venous catheters as a risk factor for disseminated phaeohyphomycosis?Clin Infect Dis. 2002 Oct 15;35(8):1022-3; author reply 1023-4. doi: 10.1086/342890. Clin Infect Dis. 2002. PMID: 12355394 No abstract available.
Similar articles
-
Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases.Med Mycol. 2009 Jun;47(4):359-70. doi: 10.1080/13693780802524506. Med Mycol. 2009. PMID: 19031336 Review.
-
Phaeohyphomycosis in a tertiary care cancer center.Clin Infect Dis. 2009 Apr 15;48(8):1033-41. doi: 10.1086/597400. Clin Infect Dis. 2009. PMID: 19267655
-
Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.Clin Infect Dis. 2005 Jan 1;40(1):89-99. doi: 10.1086/426445. Epub 2004 Dec 8. Clin Infect Dis. 2005. PMID: 15614697
-
Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi.J Chemother. 2003 Nov;15 Suppl 2:36-47. doi: 10.1179/joc.2003.15.Supplement-2.36. J Chemother. 2003. PMID: 14708965 Review.
-
Primary central nervous system phaeohyphomycosis: a review of 101 cases.Clin Infect Dis. 2004 Jan 15;38(2):206-16. doi: 10.1086/380635. Epub 2003 Dec 19. Clin Infect Dis. 2004. PMID: 14699452 Review.
Cited by
-
Disseminated Aspergillus citrinoterreus and concurrent localized dermal phaeohyphomycosis in an immunosuppressed dog.Clin Case Rep. 2024 Feb 22;12(2):e7573. doi: 10.1002/ccr3.7573. eCollection 2024 Feb. Clin Case Rep. 2024. PMID: 38405361 Free PMC article.
-
[Fungal infection by Cladophialophora bantiana and development of cerebral phaeohyphomycosis. A systematic review of 58 case reports].Rev Neurol. 2023 Oct 16;77(8):185-196. doi: 10.33588/rn.7708.2023145. Rev Neurol. 2023. PMID: 37807883 Free PMC article. Spanish.
-
In host evolution of Exophiala dermatitidis in cystic fibrosis lung micro-environment.G3 (Bethesda). 2023 Aug 9;13(8):jkad126. doi: 10.1093/g3journal/jkad126. G3 (Bethesda). 2023. PMID: 37293838 Free PMC article.
-
The Distinction between Dematiaceous Molds and Non-Dematiaceous Fungi in Clinical and Spiked Samples Treated with Hydrogen Peroxide Using Direct Fluorescence Microscopy.J Fungi (Basel). 2023 Feb 9;9(2):227. doi: 10.3390/jof9020227. J Fungi (Basel). 2023. PMID: 36836341 Free PMC article.
-
Race and ethnicity: Risk factors for fungal infections?PLoS Pathog. 2023 Jan 5;19(1):e1011025. doi: 10.1371/journal.ppat.1011025. eCollection 2023 Jan. PLoS Pathog. 2023. PMID: 36602962 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
